Petrosynol
Latest Information Update: 11 Nov 2002
Price :
$50 *
At a glance
- Originator Nonindustrial source
- Class
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cardiovascular disorders
Most Recent Events
- 28 Mar 2001 Preclinical development for Cardiovascular disorders in Japan (Unknown route)